IPRIPR2025-01269Institution Denied
Fresenius Kabi SwissBiosim, GmbH et al.v.Regeneron Pharmaceuticals, Inc.
IPR challenge of US 10828345.
Type
IPR
Filed
Jul 14, 2025
Instituted
Jan 9, 2026
Decided
Jan 9, 2026
Patent
Application
16159282
Inventor
George D. Yancopoulos
Granted
Nov 10, 2020
01
Timeline
3 milestones
2025-07-14Petition filed
2026-01-09Institution
2026-01-09Terminated
02
Parties & counsel
Petitioner
Fresenius Kabi SwissBiosim, GmbH et al.
Counsel
Aly, Imronet al
Patent Owner
Regeneron Pharmaceuticals, Inc.
Counsel
Berl, Davidet al
03
Docket
Documents are mirrored from the PTAB e-file system. Filer is as stated on the face of the filing.
SOURCE · USPTO PTAB E2EView on Unified Patents →